insights_auto
Why is ORX down 2,74%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
0,85 SEK
arrow_downward
-2,74%(-0,024) 1D
16 ნოე, 11:14:06 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
0,89 SEK
High
0,89 SEK
Low
0,82 SEK
Mkt. cap
298,61 მლნ.
Avg. vol.
777,72 ათ.
Volume
205,20 ათ.
P/E ratio
0,06
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 მლნ.
No. of employees
55
Open
0,89 SEK
High
0,89 SEK
Low
0,82 SEK
Mkt. cap
298,61 მლნ.
Avg. vol.
777,72 ათ.
Volume
205,20 ათ.
P/E ratio
0,06
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 მლნ.
No. of employees
55
News stories
From web sources and news partners
Investing.com
·
1 საათის წინ
Morgan Stanley raises S&P 500 target on earnings growth, lower oil and AI adoption
MarketWatch
·
51 წუთის წინ
Stock Market Today: Dow, S&P 500 and Nasdaq are set to fall as investors await Nvidia results and Anthropic's IPO this week: live updates
The Motley Fool
·
2 საათის წინ
The S&P 500 Looks Cheaper Than It Has in Over 3 Years, but There’s a Catch
Billionaires.Africa
·
58 წუთის წინ
American billionaire Elon Musk's SpaceX eyes S&P 500 entry through Tesla merger
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEOნიკოლაი სორენსენი
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com